MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes

Oncogene

Volumn 33, Issue 40, 2014, Pages 4813-4822

  Liu, F ^a   Gong, J ^a   Huang, W ^a   Wang, Z ^b   Wang, M ^a   Yang, J ^a   Wu, C ^a   Wu, Z ^a   Han, B ^a  

^a THE AFFILIATED CHANGZHOU NO 2 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase 8; Cell proliferation; Glioma; MIR 106b 5p; Retinoblastoma like (RBL1 2)

Indexed keywords

CASPASE 8; MICRORNA; MICRORNA 106B 5P; PROTEIN P107; PROTEIN P130; RNA; UNCLASSIFIED DRUG; CASP8 PROTEIN, HUMAN; MIRN106 MICRORNA, HUMAN; RBL1 PROTEIN, HUMAN; RBL2 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN TISSUE; CANCER GRADING; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GLIOMA; GLIOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; RNA INTERFERENCE; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; BRAIN TUMOR; CANCER TRANSPLANTATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; GLIOBLASTOMA; HEK293 CELL LINE; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CARCINOGENESIS; CASPASE 8; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GLIOBLASTOMA; HEK293 CELLS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM TRANSPLANTATION; RETINOBLASTOMA-LIKE PROTEIN P107; RETINOBLASTOMA-LIKE PROTEIN P130; RNA INTERFERENCE; TUMOR BURDEN;

EID: 84921821254     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.428     Document Type: Article

References (31)

1. Louis DN, Ohgaki H., Wiestler OD, Cavenee WK, Burger PC, Jouvet A. WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97-109.
2. Louis DN. Molecular pathology of malignant gliomas. Annu Rev Pathol 2006;1:97-117.
3. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med 2008;359:492-507.
4. Bushati N, Cohen SM. MicroRNA functions. Annu Rev Cell Dev Biol 2007;23:175-205.
5. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-838.
6. Zhang Y, Dutta A, Abounader R. The role of microRNAs in glioma initiation and progression. Front Biosci 2012;17:700-712.
7. Cai K, Wang Y, Bao X. MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma. J Exp Clin Cancer Res 2011;30:73.
8. Li B, Shi XB, Nori D, Chao CK, Chen AM, Valicenti R et al. Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells. Prostate 2011;71:567-574.
9. Li Y, Tan W, Neo TW, Aung MO, Wasser S, Lim SG et al. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci 2009;100:1234-1242.
10. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, De Martino I et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008;13:272-286.
11. Smith AL, Iwanaga R, Drasin DJ, Micalizzi DS, Vartuli RL, Tan AC et al. The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene 2012;31:5162-5171.
12. Malzkorn B, Wolter M, Liesenberg F, Grzendowski M, Stuhler K, Meyer HE et al. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol 2010;20:539-550.
13. Bogler O, Mikkelsen T. Angiogenesis and apoptosis in glioma: two arenas for promising new therapies. J Cell Biochem 2005;96:16-24.
14. Garcia DM, Baek D, Shin C, Bell GW, Grimson A, Bartel DP. Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol 2011;18:1139-1146.
15. Reczko M, Maragkakis M, Alexiou P, Grosse I, Hatzigeorgiou AG. Functional microRNA targets in protein coding sequences. Bioinformatics 2012;28:771-776.
16. Wang X. miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 2008;14:1012-1017.
17. Guo CP, Liu KW, Luo HB, Chen HB, Zheng Y, Sun SN et al. Potent anti-tumor effect generated by a novel human papillomavirus (HPV) antagonist peptide reactivating the pRb/E2F pathway. PLoS One 2011;6:e17734.
18. Takahashi K, Kawai T, Kumar H, Sato S, Yonehara S, Akira S. Roles of caspase-8 and caspase-10 in innate immune responses to double-stranded RNA. J Immunol 2006;176:4520-4524.
19. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 2008;68:6162-6170.
20. Hu S, Dong TS, Dalal SR, Wu F, Bissonnette M, Kwon JH et al. The microbederived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer. PLoS One 2011;6:e16221.
21. Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM et al. Micro-RNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 2008;28:2167-2174.
22. Kan T, Sato F, Ito T, Matsumura N, David S, Cheng Y et al. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 2009;136:1689-1700.
23. Wang H, Liu J, Zong Y, Xu Y, Deng W, Zhu H et al. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-beta type II receptor. Brain Res 2010;1357:166-174.
24. Hudson RS, Yi M, Esposito D, Glynn SA, Starks AM, Yang Y et al. MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer. Oncogene 2012;32:4139-4147.
25. Wu H, Wang F, Hu S, Yin C, Li X, Zhao S et al. MiR-20a and miR-106b negatively regulate autophagy induced by leucine deprivation via suppression of ULK1 expression in C2C12 myoblasts. Cell Signal 2012;24:2179-2186.
26. Wang X, Zhang H, Zhang A, Han L, Wang K, Liu R et al. Upregulation of miR-20a and miR-106b is involved in the acquisition of malignancy of pediatric brainstem gliomas. Oncol Rep 2012;28:1293-1300.
27. Trompeter HI, Abbad H, Iwaniuk KM, Hafner M, Renwick N, Tuschl T et al. MicroRNAs MiR-17, MiR-20a, and MiR-106b act in concert to modulate E2F activity on cell cycle arrest during neuronal lineage differentiation of USSC. PLoS One 2011;6:e16138.
28. Ashley DM, Riffkin CD, Muscat AM, Knight MJ, Kaye AH, Novak U et al. Caspase 8 is absent or low in many ex vivo gliomas. Cancer 2005;104:1487-1496.
29. Sharif A, Prevot V. Isolation and culture of human astrocytes. Methods Mol Biol 2012;814:137-151.
30. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002;296:550-553.
31. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007;4:721-726.